Hypoxia-directed cancer therapy

Author： Frazier Monica C   Simons Jonathan W   Zhong Hua   Mabjeesh Nicola J  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.6, 2002-06, pp. : 777-788

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Therapy By Targeting Hypoxia-Inducible Factor-1

By  

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 782-796

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Regulation of Epithelial-Mesenchymal Transition by Hypoxia in Cancer: Targets and Therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 10, 2015-03 ,pp. : 1272-1278

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 Gene-directed Enzyme Prodrug Therapy (GDEPT) for Cancer

By  

Current Pharmaceutical Design, Vol. 8, Iss. 15, 2002-07 ,pp. : 1405-1416

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Cell Hypoxia and the Hypoxia-Response Signaling System as a Target for Prostate Cancer Therapy

By  

Current Drug Targets, Vol. 4, Iss. 3, 2003-04 ,pp. : 191-196

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokine-Directed Therapy in Asthma

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-09 ,pp. : 263-269

Bentham Science Publishers

Access to resources Recommend Favorite